Cathie Wood Adaptive Biotechnologies Corp Transaction History

Ark Investment Management LLC

$9.28 Billion
Q1 2025

A detailed history of Cathie Wood (Ark Investment Management LLC) transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Ark Investment Management LLC holds 7,732,570 shares of ADPT stock, worth $71.1 Million. This represents 0.62% of its overall portfolio holdings.

Number of Shares

7,732,570

Previous 9,424,074 17.95%

Holding current value

$71.1 Million

Previous $56.5 Million 1.61%

% of portfolio

0.62%

Previous 0.49%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 07, 2025	SELL	$6.07 - $8.66 $10.3 Million - $14.6 Million	-1,691,504 Reduced 17.95%	7,732,570 $57.5 Million
Q4 2024 Feb 04, 2025	SELL	$4.37 - $6.78 $9.51 Million - $14.8 Million	-2,177,060 Reduced 18.77%	9,424,074 $56.5 Million
Q3 2024 Oct 31, 2024	BUY	$3.37 - $5.12 $637,381 - $968,366	189,134 Added 1.66%	11,601,134 $59.4 Million
Q2 2024 Jul 26, 2024	BUY	$2.34 - $3.96 $1.99 Million - $3.37 Million	850,704 Added 8.05%	11,412,000 $41.3 Million
Q1 2024 Apr 18, 2024	SELL	$2.88 - $4.8 $6.47 Million - $10.8 Million	-2,245,217 Reduced 17.53%	10,561,296 $33.9 Million
Q4 2023 Jan 17, 2024	BUY	$3.46 - $5.33 $4.49 Million - $6.91 Million	1,297,205 Added 11.27%	12,806,513 $62.8 Million
Q3 2023 Oct 18, 2023	BUY	$5.07 - $8.44 $5.35 Million - $8.91 Million	1,055,556 Added 10.1%	11,509,308 $62.7 Million
Q2 2023 Jul 10, 2023	BUY	$6.19 - $8.78 $7.73 Million - $11 Million	1,248,627 Added 13.56%	10,453,752 $70.1 Million
Q1 2023 Apr 17, 2023	BUY	$7.8 - $10.11 $30,264 - $39,226	3,880 Added 0.04%	9,205,125 $81.3 Million
Q4 2022 Jan 24, 2023	SELL	$6.26 - $9.34 $847,441 - $1.26 Million	-135,374 Reduced 1.45%	9,201,245 $0
Q3 2022 Oct 17, 2022	BUY	$6.5 - $12.67 $3.66 Million - $7.14 Million	563,601 Added 6.42%	9,336,619 $66.5 Million
Q2 2022 Jul 11, 2022	BUY	$6.4 - $14.73 $6.81 Million - $15.7 Million	1,063,352 Added 13.79%	8,773,018 $68.6 Million
Q1 2022 Apr 19, 2022	BUY	$10.12 - $28.9 $20.4 Million - $58.1 Million	2,011,798 Added 35.31%	7,709,666 $107 Million
Q4 2021 Jan 28, 2022	BUY	$25.17 - $36.85 $21.2 Million - $31 Million	841,447 Added 17.33%	5,697,868 $160 Million
Q3 2021 Nov 12, 2021	BUY	$30.02 - $39.87 $14.7 Million - $19.5 Million	489,444 Added 11.21%	4,856,421 $165 Million
Q2 2021 Aug 05, 2021	BUY	$32.22 - $44.59 $28.8 Million - $39.8 Million	893,067 Added 25.71%	4,366,977 $178 Million
Q1 2021 May 13, 2021	BUY	$37.26 - $67.74 $71.8 Million - $131 Million	1,928,207 Added 124.75%	3,473,910 $140 Million
Q4 2020 Feb 12, 2021	BUY	$45.01 - $65.47 $29.8 Million - $43.3 Million	660,981 Added 74.71%	1,545,703 $91.4 Million
Q3 2020 Oct 30, 2020	BUY	$35.79 - $48.81 $20.6 Million - $28.1 Million	575,584 Added 186.19%	884,722 $43 Million
Q2 2020 Aug 11, 2020	BUY	$24.95 - $48.38 $7.71 Million - $15 Million	309,138 New	309,138 $15 Million

Others Institutions Holding ADPT

# of Institutions

246

Shares Held

156M

Call Options Held

44.3K

Put Options Held

47.8K

View Full List

About Adaptive Biotechnologies Corp

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $1.31B
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

More about ADPT

Track Cathie Wood's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ark Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ark Investment Management LLC and Cathie Wood with notifications on news.

Account